Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Greenberg

Showing results (131-140 of 189) with videos related to

Pageof 19
Sort By:
The Canadian Journal of Cardiology|April 19, 2007
A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and designGuillermo Torre-Amione, Robert C Bourge, Wilson S Colucci, et al.
European Journal of Heart Failure|September 23, 2020
Association of left ventricular ejection fraction with worsening renal function in patients with acute heart failure: insights from the RELAX-AHF-2 studySiting Feng, Satit Janwanishstaporn, John R Teerlink, et al.
Circulation|January 16, 2008
Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemiaJalal K Ghali, Inder S Anand, William T Abraham, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 2, 2024
Performance of risk models to predict mortality risk for patients with heart failure: evaluation in an integrated health systemFaraz S Ahmad, Ted Ling Hu, Eric D Adler, et al.
Frontiers in Pharmacology|August 21, 2023
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's diseaseBen Boyarko, Sonia Podvin, Barry Greenberg, et al.
European Journal of Heart Failure|December 10, 2024
Machine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fractionLuca Monzo, Emmanuel Bresso, Kenneth Dickstein, et al.
BMJ Open|August 11, 2023
Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HFAbhinav Sharma, Daniel Caldeira, Amir Razaghizad, et al.
ESC Heart Failure|October 1, 2019
Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trialJan Biegus, Biniyam Demissei, Douwe Postmus, et al.
Cardiology|November 20, 2010
Low lymphocyte ratio as a novel prognostic factor in acute heart failure: results from the Pre-RELAX-AHF studyOlga Milo-Cotter, John R Teerlink, Marco Metra, et al.
Journal of the American College of Cardiology|March 19, 2013
Primary results of the HABIT Trial (heart failure assessment with BNP in the home)Alan Maisel, Denise Barnard, Brian Jaski, et al.
Pageof 19

Showing results (131-140 of 189) with videos related to

Sort By:
Pageof 19
The Canadian Journal of Cardiology|April 19, 2007
A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and designGuillermo Torre-Amione, Robert C Bourge, Wilson S Colucci, et al.
European Journal of Heart Failure|September 23, 2020
Association of left ventricular ejection fraction with worsening renal function in patients with acute heart failure: insights from the RELAX-AHF-2 studySiting Feng, Satit Janwanishstaporn, John R Teerlink, et al.
Circulation|January 16, 2008
Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemiaJalal K Ghali, Inder S Anand, William T Abraham, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 2, 2024
Performance of risk models to predict mortality risk for patients with heart failure: evaluation in an integrated health systemFaraz S Ahmad, Ted Ling Hu, Eric D Adler, et al.
Frontiers in Pharmacology|August 21, 2023
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's diseaseBen Boyarko, Sonia Podvin, Barry Greenberg, et al.
European Journal of Heart Failure|December 10, 2024
Machine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fractionLuca Monzo, Emmanuel Bresso, Kenneth Dickstein, et al.
BMJ Open|August 11, 2023
Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HFAbhinav Sharma, Daniel Caldeira, Amir Razaghizad, et al.
ESC Heart Failure|October 1, 2019
Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trialJan Biegus, Biniyam Demissei, Douwe Postmus, et al.
Cardiology|November 20, 2010
Low lymphocyte ratio as a novel prognostic factor in acute heart failure: results from the Pre-RELAX-AHF studyOlga Milo-Cotter, John R Teerlink, Marco Metra, et al.
Journal of the American College of Cardiology|March 19, 2013
Primary results of the HABIT Trial (heart failure assessment with BNP in the home)Alan Maisel, Denise Barnard, Brian Jaski, et al.
Pageof 19